Showing results (331-340 of 575) with videos related to
Sort By:
Pageof 58
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.Neurology|August 1, 1981
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington diseaseR E Burke, S Fahn, R Mayeux, et al.Neurology|February 1, 1992
Motor blocks in Parkinson's diseaseN Giladi, D McMahon, S Przedborski, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Neurotoxicity of levodopa on catecholamine-rich neuronsM A Mena, B Pardo, M J Casarejos, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Glycine involvement in DDT-induced myoclonusD D Truong, J Garcia De Yebenes, G Pezzoli, et al.Archives of Neurology|October 27, 2001
Clinical correlates of action tremor in Parkinson diseaseE D Louis, G Levy, L J Côte, et al.Brain Research Bulletin|February 1, 1991
Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brainV Jackson-Lewis, S Przedborski, V Kostic, et al.Archives of Neurology|May 1, 1996
Delayed-onset cerebellar syndromeE D Louis, T Lynch, B Ford, et al.Neurology|October 1, 1986
Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioidsW A Hening, A Walters, N Kavey, et al.Archives of Neurology|March 1, 1988
An estimate of the prevalence of dementia in idiopathic Parkinson's diseaseR Mayeux, Y Stern, R Rosenstein, et al.Pageof 58